AATec Medical GmbH
PrivateLast Round
Series A
Apr 15, 2025
Total Funding Raised
$7.52M
Company Overview
AATec Medical GmbH is a biotechnology company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of respiratory inflammatory diseases, airway infections and rare diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Medical Devices
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AATec Medical GmbH Comparables
Compare AATec Medical GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ReCode Therapeutics | 63% | |
| Takeda | 63% | |
| Adverum Biotechnologies Inc | 62% |
AATec Medical GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Apr 15, 2025 | ||||
| Seed | Jul 17, 2023 |
AATec Medical GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SPRIND | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 2, 2025
Grew 50% QoQ from 6 to 9 employees.
- Apr 15, 2025
$4.5M round led by SPRIND
Recent news
Latest coverage and updates
- is_developingOct 14, 2026
AATec Medical GmbH is developing a new class of therapeutics for respiratory diseases, with ATL-105 advancing into clinical development as an inhaled recombinant alpha-1 antitrypsin therapy.
AATec Medical GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about AATec Medical GmbH's valuation, stock price, and market status.
Is AATec Medical GmbH a public or private company?
AATec Medical GmbH is a private company.
What is the current stock price of AATec Medical GmbH?
AATec Medical GmbH is a private company, so its shares have no public market price. Caplight tracks AATec Medical GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AATec Medical GmbH worth (valuation)?
Valuation information for AATec Medical GmbH is not publicly available.
Can I buy AATec Medical GmbH stock?
AATec Medical GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AATec Medical GmbH's last funding round?
AATec Medical GmbH's most recent funding round was Series A on April 15, 2025.
Who are the main investors in AATec Medical GmbH?
Key investors in AATec Medical GmbH include SPRIND.
Will AATec Medical GmbH IPO soon?
No public IPO plans have been announced for AATec Medical GmbH.
How can I track AATec Medical GmbH secondary market activity?
Caplight tracks bids, offers, and trades in AATec Medical GmbH's shares on secondary markets.